These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 12698098

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital.
    Grow WB, Moreb JS, Roque D, Manion K, Leather H, Reddy V, Khan SA, Finiewicz KJ, Nguyen H, Clancy CJ, Mehta PS, Wingard JR.
    Bone Marrow Transplant; 2002 Jan; 29(1):15-9. PubMed ID: 11840139
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Outbreak of aspergillosis infections among lung transplant recipients.
    Raviv Y, Kramer MR, Amital A, Rubinovitch B, Bishara J, Shitrit D.
    Transpl Int; 2007 Feb; 20(2):135-40. PubMed ID: 17239021
    [Abstract] [Full Text] [Related]

  • 5. Risk factors for invasive aspergillosis in living donor liver transplant recipients.
    Osawa M, Ito Y, Hirai T, Isozumi R, Takakura S, Fujimoto Y, Iinuma Y, Ichiyama S, Tanaka K, Mishima M.
    Liver Transpl; 2007 Apr; 13(4):566-70. PubMed ID: 17394155
    [Abstract] [Full Text] [Related]

  • 6. High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation.
    Labbé AC, Su SH, Laverdière M, Pépin J, Patiño C, Cohen S, Kiss T, Lachance S, Sauvageau G, Busque L, Roy DC, Roy J.
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1192-200. PubMed ID: 17889356
    [Abstract] [Full Text] [Related]

  • 7. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ, Comber H, O'Lorcain P, O'Kelly P, Conlon PJ, Murphy GM.
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [Abstract] [Full Text] [Related]

  • 8. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation.
    Hellinger WC, Bonatti H, Yao JD, Alvarez S, Brumble LM, Keating MR, Mendez JC, Kramer DJ, Dickson RC, Harnois DM, Spivey JR, Hughes CB, Nguyen JH, Steers JL.
    Liver Transpl; 2005 Jun; 11(6):656-62. PubMed ID: 15915482
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients.
    Post MJ, Lass-Floerl C, Gastl G, Nachbaur D.
    Transpl Infect Dis; 2007 Sep; 9(3):189-95. PubMed ID: 17511828
    [Abstract] [Full Text] [Related]

  • 11. Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study.
    Gavalda J, Len O, San Juan R, Aguado JM, Fortun J, Lumbreras C, Moreno A, Munoz P, Blanes M, Ramos A, Rufi G, Gurgui M, Torre-Cisneros J, Montejo M, Cuenca-Estrella M, Rodriguez-Tudela JL, Pahissa A, RESITRA (Spanish Network for Research on Infection in Transplantation).
    Clin Infect Dis; 2005 Jul 01; 41(1):52-9. PubMed ID: 15937763
    [Abstract] [Full Text] [Related]

  • 12. Real-time PCR on the first galactomannan-positive serum sample for diagnosing invasive aspergillosis in liver transplant recipients.
    Botterel F, Farrugia C, Ichai P, Costa JM, Saliba F, Bretagne S.
    Transpl Infect Dis; 2008 Oct 01; 10(5):333-8. PubMed ID: 18627580
    [Abstract] [Full Text] [Related]

  • 13. [Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole].
    Mattner F, Chaberny IF, Weissbrodt H, Fischer S, Gastmeier P, Haubitz B, Gottlieb J, Mattner L, Strueber M.
    Mycoses; 2005 Oct 01; 48 Suppl 1():51-5. PubMed ID: 15826288
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients.
    Oshima K, Kanda Y, Asano-Mori Y, Nishimoto N, Arai S, Nagai S, Sato H, Watanabe T, Hosoya N, Izutsu K, Asai T, Hangaishi A, Motokura T, Chiba S, Kurokawa M.
    J Antimicrob Chemother; 2007 Aug 01; 60(2):350-5. PubMed ID: 17584800
    [Abstract] [Full Text] [Related]

  • 17. Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000.
    Zaoutis TE, Heydon K, Chu JH, Walsh TJ, Steinbach WJ.
    Pediatrics; 2006 Apr 01; 117(4):e711-6. PubMed ID: 16533892
    [Abstract] [Full Text] [Related]

  • 18. Aspergillus pneumonia in renal transplant recipients.
    Zhang XD, Hu XP, Yin H, Wang W, Zhang X, Ma LL, Wang Y.
    Chin Med J (Engl); 2008 May 05; 121(9):791-4. PubMed ID: 18701042
    [Abstract] [Full Text] [Related]

  • 19. Associations of characteristics of renal transplant recipients with clinicians' perceptions of adherence to immunosuppressant therapy.
    Chisholm MA, Kwong WJ, Spivey CA.
    Transplantation; 2007 Nov 15; 84(9):1145-50. PubMed ID: 17998870
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.